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A B S T R A C T
To identify the scales to assess sleep disorders applied to women with climacteric stage. Bibliographical research
without intervention, the available information in scientiﬁc databases. Performed in PubMed, ScienceDirect,
Scopus, Ebscohos OvidSP and Health Library. The words used in this article: insomnia, adjustment sleep
disorder, questionnaires, studies and menopause. Publications of all types were included. Seven scales were
identiﬁed: Insomnia Severity Index, Athens Insomnia Scale, Pittsburgh Quality of sleep Index, Epworth
Sleepiness Scale, Jenkins Sleep Scale, Basic Nordic Sleep Questionnaire and The St Mary's Hospital Sleep
Questionnaire. There are validated scales in multiple languages and considered appropriate for studying sleep
disorders.
1. Introduction
Several ways to classify sleep disorders (SD) have been proposed.
The most important is the International Classiﬁcation of Sleep
Disorders [ICSD-2] with numerous subdivisions and specialized ap-
proaches [1]; other one is proposed by the American Psychiatric
Association in the Diagnostic and Statistical Manual of Mental
Disorders [DSM-5] [2], which is used specially by health professionals
who are not experts in sleep medicine. Finally, there is the
International Classiﬁcation of Diseases [ICD] [3] with general medical
approach [4].
The SD are widespread and important complaints in the vital
climacteric stage [5,6]. These sleep disorders occur in approximately
30% of the general population increasing with the pass of time; it is
estimated in more than 50% of adults over 65 years old [7].
The prevalence of SD varies with the menopausal status, with
estimated ranges between 39% and 47% in perimenopause and 35–
60% in postmenopausal women [5,7,8]. In a study carried out in eleven
cities from Latin America, which involved 6.079 women aged 40–59
years, insomnia was reported in 56.6% of the population, with poor
quality of sleep or both [9]. Monterrosa [5] has reported that 57.1% of
Colombian women in climacteric, who live in the Caribbean and the
Paciﬁc coasts, had poor quality of sleep when they were diagnosed by
the quality of sleep index of Pittsburgh.
Insomnia is the main SD, being approximately two times more
common in women than in men [6,10]. It is characterized by diﬃculty
to sleep, staying asleep or diﬃculty to get a restful sleep. It is
recommended to specify an episodic, persistent or recurrent event, or
whether they are associated with a concurrent mental disorder
unrelated to sleep, with a medical condition or another sleep disorder
[11,12].
Among the types of SD, insomnia, in particular, may arise situa-
tions that impair the quality of life such as decreased concentration and
attention, feelings of fatigue and physical or mental exhaustion,
decreased motivation, irritability, diﬃculty in interpersonal relation-
ships and general complications [11]. It has been noted that SD could
often be accompanied by depression, anxiety or cognitive changes,
while insomnia and excessive daytime sleepiness are risk factors for the
later development of mental illness. The interpretation of SD as an
expression of mental diseases allows preventive intervention in mental
health [2]. Sleep disorders restrict the appropriate recovery/cell repair
that comes during sleep and aﬀect adversely the emotional state of
women [11].
The physiology of sleep-wakefulness cycle may be aﬀected as a
result of changes in ovarian hormone synthesis. The menopause and
the reduction in the availability of endogenous estradiol, that occur
within the climacteric, have been considered risk factors for SD. The
eﬀect could be directly inﬂuenced by changes in the steroid proﬁle, as a
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result of variations in body temperature by the presence of hot ﬂashes,
circadian rhythm disturbances or higher reactivity to stress [11–14].
There is controversy about whether severity criteria should be
assessed in the presence of insomnia or in the functional impairment
that this could entailed, which always should be considered due to they
could aﬀect the quality of life further than sleep disturbances [15]. The
diagnostic method of SD is the polysomnography, considered the gold
standard; however, it has some limitations due to it does not evaluate
quality of sleep and the impact of SD on daily activities. In additionally,
to carry out the procedure is necessary to have a quiet room, as close as
possible to the home address, where the patient could sleep and
another room where the necessary sleep equipment could be installed
[16].
Sleep scales are tools to identify, in a subjective way, SD [9,17].
They oﬀer advantages as easy application and interpretation and the
availability to study diﬀerent disorders [5,18]. These scales must have
been validated in populations and checked in the age groups. Since the
high prevalence of SD in climacteric is necessary to know the
diﬀerences among scales that are available to study adequately these
women, and to establish the deterioration of the quality of sleep or the
presence of any diﬀerent types of SD [18–21]. The aim is to identify
and to describe the diﬀerent scales that have been used to assess SD in
climacteric.
2. Methods
Bibliographic research without intervention was used; available
data in scientiﬁc databases was chosen between January and March in
2016.
2.1. Types of studies
All types of publications were included: clinical trials, meta-
analysis, observational studies, thematic or systematic reviews, letters
to the editor, comments and editorials related to insomnia and other
SD in climacteric women.
2.2. Research strategies
A convenient search was conducted through the databases and
electronic resources of the Universidad de Cartagena-Colombia like
Pubmed, ScienceDirect, Scopus, Ebscohost, OvidSP and Health
Library. It was considered to ﬁnish on March 3th, 2016 and was
limited to publications between 2005 and 2015, in English and
Spanish.
2.3. Keywords
The words used in this article are present in MeSH: insomnia,
adjustment sleep disorder, questionnaires, studies and menopause.
2.4. Review methods
A list of the identiﬁed titles was done, and then step by step the
repeated words were eliminated. The summary was checked in the
selected titles to identify those related to insomnia and SD. After that, a
second review was carried out to establish those abstracts who were
related to women in climacteric. And ﬁnally, those available in full text
were selected. Type of intervention: Research and thematic review in
articles, without intervention in the information obtained from sources.
3. Results
Two thousand eighty-two titles were identiﬁed: 567 (27.2%) in
Science Direct, 312 (14.9%) in Pubmed, 257 (12.4%) in Ebscohost, 783
(37.7%) in OvidSP and 163 (7.8%) in Virtual Health Library. One
thousand two hundred seven (57.9%) titles of the list remained after
removing those repeated. Two hundred ﬁfty (20.7%) abstracts were
chosen in the ﬁrst review; after the second review, 82 (32.8%) were
relevant and consistent for the goal of this investigation. Finally, 63
(76.8%) articles were selected, of which, 59 (93.6%) were included in
the review. Seven scales were identiﬁed; they have been used to study
diﬀerent types of SD in climacteric and are presented below [Table 1].
3.1. Insomnia Severity Index (ISI)
This scale is speciﬁc to study insomnia. It is a reliable, validated and
self-applicable instrument, it lets to obtain a quantitative index of
perceived severity of insomnia in the last month. The scale has seven
questions designed to detect the severity of SD, the relation with the
satisfaction experienced, the degree of functional impairment during
the day, perception of decline and the concerns related to the sleep
problem. Each item is rated on a Likert scale of ﬁve points (zero to
four) to set a score from zero to 28. The higher scores indicate very
severe insomnia; a cutoﬀ point of ten has been proposed as optimal for
detecting cases of insomnia in the population. However, the scores
could be categorized as follows: Clinically signiﬁcant insomnia: zero to
seven points; some degree of insomnia: eight to 28 points [10,20–21].
The last one is subdivided in sub-threshold insomnia or mild: eight
to 14, moderate insomnia: 15–21 and severe insomnia: 22–28 [21].
Recently, it has been described in three sub-domains: nocturnal sleep
diﬃculties, sum of questions 1–2–3, impact of insomnia during the
day, sum of questions 5–6–7 and dissatisfaction sleep with the sum of
questions 1–4–7 [19] [Appendix A].
The ISI could be applied in studies for the population in health care
consultation, given that it allows an easy approximation to identify the
presence of insomnia.
Arakane [10] found high internal consistency according to
Cronbach's alpha coeﬃcient =0.87 in a cross-sectional study carried
out in 340 healthy women of a group of inpatients visitors. They were
women aged between 40 and 59 years and he showed that 41.5% of
those, had some degree of insomnia, taking as cutoﬀ point ≥8. He also
demonstrated that 32.0% of them had mild, 7.4% moderate and 2.1%
severe insomnia. It was veriﬁed the presence of hot ﬂashes, the use of
psychotropic substances and physical inactivity, positively and signiﬁ-
cantly correlated with the total score of the ISI scale, by means of a
multiple linear regression model. Likewise, Cuadros [22] found out, in
235 Spanish women aged 40–65 years, a positive correlation between
the ISI scale and the Perceived Stress Scale (PSS) scores and the scores
Table 1
Scales to study sleep disorders in climacteric women.
Autors (Ref.) Year Scale Type of Sleep
Disorders
1 Bastien et al.
[21].
2001 Insomnia Severity Index
(ISI)
Perceived insomnia
severity
2 Soldatos et al.
[17]
2000 Athens Insomnia Scale
(AIS)
Insomnia.
Quantiﬁcation of sleep
problems.
3 Buysse et al.
[25]
1989 The Pittsburgh Sleep
Quality Index: (PSQI)
Quality of sleep
Distinguishing in good
and poor sleepers.
4 Johns [29] 1991 Epworth Sleepiness
Scale (ESS)
Daytime sleepiness
5 Jenkins et al.
[32]
1988 Jenkins Sleep Scale
(JSS)
High frequency of
sleep disorders
6 Partinem and
Gislason [35]
1995 Basic Nordic Sleep
Questionnaire (BNSQ)
Quality of sleep
7 Ellis et al. [37] 1981 The St Mary's Hospital
Sleep Questionnarie
(SMHSQ)
Quality of sleep
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in the somatic domain of the Menopause Rating Scale (MRS). This
shows a greater insomnia severity, higher perceived stress and somatic
deterioration in the quality of life.
3.2. Athens Insomnia Scale (AIS)
This scale arose from the need to develop a tool that could help
health professionals when they had to analyze the insomnia severity. It
is based on the International Classiﬁcation of Diseases criteria for
insomnia diagnosis [17]. The scale is speciﬁc in insomnia cases and it
has eight questions, the ﬁrst four are related to quantitative sleep
variables, including sleep induction, nighttime awakenings, early
morning awakenings and total sleep duration. The ﬁfth question is
about the quality of sleep in general, and the last three ones are about
insomnia eﬀects in the eﬃciency during the day. Each question could
be rated from zero (no problem) to three (very serious problem),
leaving two intermediate scores. AIS's total score is the sum of the
scores on each question and may vary from zero to 24. Scores that are
higher than six deﬁne the presence of insomnia [17]. There are many
publications with AIS, available in many languages including Spanish
[23] [Appendix B]. The scale evaluates the events experienced in the
last month; its brevity and simplicity allows its application in clinical or
community settings.
It has been noted the high degree of internal consistency with a
Cronbach's alpha of 0.90 showed by AIS in the general population [23].
It has been demonstrated that daily activities and the presence of
menopausal symptoms have an important role in the establishment of
insomnia states in Latin America. It was established in this report that
the presence of hot ﬂashes, depression, high parity and those whose
partners have suﬀered from premature ejaculation, contributed with
high scores on the AIS [24] scale in 204 women aged between 40 and
65 years old.
In a study carried out by Monterrosa [18] et al., in 1.325 Colombian
women who belong to three diﬀerent ethnic groups (afrodescendant,
indigenous and mestizo) with ages between 40 and 59 years, it was
found by means of a logistic regression, that the severe somatic and
psychological deterioration and the current tobacco consumption were
risk factors associated to the presence of insomnia. In addition, the
insomnia scale was used in this study and a high internal consistency
was reported, Cronbach's alpha=0.93.
3.3. Pittsburgh Quality of sleep Index (PSQI)
The Pittsburgh Quality of sleep Index is an instrument published in
1988 by Buysse, which was obtained from three sources: intuition and
clinical experience in patients with SD, review of quality of sleep
questionnaires proposed in the scientiﬁc literature and clinical experi-
ence with a pilot instrument applied for 18 months in ﬁeld experi-
ments. It is a self-report questionnaire that assesses quality of sleep
during the last four weeks. The PSQI does not assess the insomnia
presence or absence like ISI and AIS do. It distinguishes between bad
and good sleep of quality by measuring seven SD components:
subjective quality of sleep, sleep latency, sleep duration, habitual sleep
eﬃciency, sleep disturbances, use of sleep medication, and daytime
dysfunction. The ISI application allows the orientation about which are
the sleep components compromised and which ones allow following the
characteristics of the SD. This scale is used to know the quality of sleep
[5].
The PSQI has nineteen questions, grouped into ten questions to
answer from zero to three in Likert range, a zero score indicates ease,
while three indicates severe diﬃculty, allowing two intermediate
scores. The score of the seven SD components are summed to obtain
an overall score, from zero to 21 points: zero indicates easy sleep and
21 the higher severity [25] [Appendix C]. The following are the deﬁned
components by PSQI scale: qualities of sleep, sleep onset latency, sleep
duration and sleep disturbances, medication and daytime dysfunction.
It is complex to calculate each component from the form applied, which
restricts its use for professional consultations or individual studies.
However, it is easy to apply in group evaluations or research studies.
Buysse [25] proposed a cutoﬀ point of 5 to predict poor quality or
good quality of sleep. Score ≥5 deﬁnes poor sleepers, with sensitivity of
89.6% and 86.5% of speciﬁcity. The PSQI has been validated in several
languages and in diﬀerent populations. Macías [26] found high internal
consistency identifying Cronbach =0.81. In other study, Escobar-
Cordoba [27] found Cronbach's alpha =0.77 in a group aged between
6 and 90 years. Additionally, he reported diﬀerences in the score of the
PSQI scale according to the characteristics of individuals, with higher
scores in elderly people compared to younger people, higher in those
with SD; and also, in those patients who took hypnotics and with
insomnia.
In a study carried out by Blümel [9], it was found that poor quality
of sleep worsened with age and with the change of menopausal status,
especially reducing sleep eﬃciency and sleep latency but with higher
use of hypnotics. Vasomotor symptoms (VMS), depressed mood and
anxiety were associated with SD in this study. Women who had poor
quality of sleep doubled the severity of symptoms, with six or eight
times greater risk of deterioration in their quality of life. Anxiety,
depression and hot ﬂashes were signiﬁcant risk factors related to the
presence of poor quality of sleep. Better sleep quality was observed in
women with better educational levels.
In other study in a group of women from Iran [28], with 52.9 ± 3.3
average age, was found signiﬁcant correlation between poor quality
sleep measured with PSQI and variables like educational and profes-
sional level, employment status and partner economic situation.
3.4. Epworth Sleepiness Scale (ESS)
It is a short questionnaire, self-administered proposed by Murray
W. Johns in 1991 from Epworth Hospital in Melbourne-Australia. The
ESS is a questionnaire that evaluates the tendency to fall asleep in eight
sedentary situations: sitting and reading, watching TV, sitting inactive
in a public place, as a passenger in a car for an hour of travel, sitting
and talking with somebody, lying down and relaxing in the evening,
sitting after having lunch without alcohol or in car during a traﬃc jam.
It was designed to be self-administered with questions and many
options for each Likert item with scores from zero to three: zero never,
one mild, two moderate and three severe. The total score in the scale
ranges from zero to 24. The daytime insomnia severity is higher when
the score goes up. Thereby, a score from zero to seven indicates normal
daytime insomnia, a score from eight to nine shows excessive mild
daytime insomnia, a score from 10 to 15 moderate and 16 or more
score is indicative of severe daytime sleepiness. These scores are
coherent with eight items that has the instrument and total scores
measured by Cronbach's alfa, according to specialist, ﬂuctuates from
0.73 to 0.88 [29].
The ESS has been translated to Spanish, Portuguese, Italian,
German, Swedish, Finnish, Greek, French, Mandarin, Japanese and
Turkish. This tool has not been validated to be used through telephone
interviews. It allows knowing how SD aﬀect in the activities of the next
day. Appendix D.
Daytime sleepiness is a sleep disorder that has many described risk
factors. Chedraui found [30] that postmenopausal status, physical
inactivity and hot ﬂashes were the main risk factors in the increase
of the daytime sleepiness in a cross-sectional study done in 149 women
aged between 40 and 59 years; in accordance with Yazdi [31], who
carried out the speciﬁc Questionnaire Quality of Life Menopause
(MENQOL) in 380 women aged 50 and 60 years. The frequency of
severe and moderate insomnia was 8.4% and 11.8%, respectively.
Severe daytime sleepiness was present in 27.9% of the participants.
Insomnia and daytime sleepiness had an independent negative impact
on each domain and the total score of the questionnaire MENQOL.
This study showed internal consistency with Cronbach's alpha values
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for ISI and ESS from 0.82 to 0.78, respectively.
3.5. Jenkins Sleep Scale (JSS)
C. David Jenkins designed this instrument in 1988 based on data
from two populations that answered self-report scales with three and
four questions, to follow common sleep problems in clinical areas. Four
items evaluated, in the last month, the diﬃculty to fall asleep, wake up
at night, diﬃculty to stay asleep and wake up exhausted in the morning
instead of sleeping as usual. Each item is rated on a Likert scale from
zero to ﬁve, where zero is never, 1 is one to three 1–3 days, two is four
to seven days, three is eight to 14 days, four is 15–21 days and ﬁve is
22–28 days. The scale allows scoring from zero to 20. To get a total
score from one to 11 deﬁnes a little of SD, while a score ≥12 identiﬁes
high frequency of SD [32] [Appendix E].
It was found that SD prevalence was 37.5%, further signiﬁcant
association was observed related to menopausal status, presence of
urinary incontinence, being under psychiatric treatment and psycho-
social experience like domestic violence, healthy quality perception,
educational level attained and regular exercising, in a study in women
aged 40–59 years. The JSS scale scores were positively correlated with
higher scores of somatic symptoms in menopause, evaluated with the
speciﬁc scale of menopausal symptoms: Menopause Rating Scale
(MRS). It was found that the internal consistency for JSS scale was
0.78 and 0.79 for MRS scale [33].
3.6. Basic Nordic Sleep Questionnaire (BNSQ)
The Scandinavian Sleep Research Society formed a working group
in 1988 to develop a standardized questionnaire that could be used as a
basis for studying the SD. The BNSQ scale has 21 questions that
analyzes the most common complaints about sleep in the last three
months. Most questions could be immediately answered in each box;
some of them must be answered with numbers according to time, some
in minutes, hours or days. The last question is open, where SD could be
described in free text [34].
The BNSQ was originally developed in English. The basic questions
have several possible answers: one is never or less than once a month,
two is less than once a week, three is one to two days a week, four is
three to ﬁve days per week and ﬁve is every day or almost every day.
Questions about speciﬁc rare events could be subdivided in never and
less than once a month. Habitual snoring is deﬁned as snoring every
night or almost every night. The BNSQ has been widely used in studies
in Nordic countries in recent years because it is a valid tool [35]
[Appendix F].
Donati [36] checked the quality of sleep with BNSQ scale, quality of
life with Short Form-12 questions and hot ﬂashes intensity using a
visual scale in 2428 postmenopausal women assessed by a cross-
sectional study carried out in Italy. She found that women with lower
quality of life reported worse quality of sleep. It also was found that
those women, who did not use hormone therapy, reported more
frequent forms of poor sleep, more troubles to sleep and sleep
problems.
The subjective [11] sleep in 91 premenopausal women aged
between 44 and 48 years was checked and compared with the
subjective sleep in postmenopausal women aged between 53 and 58
years in another study. It was found that the postmenopausal total
sleep time, night time sleep and the number of awakenings on
weekdays were shorter compared to premenopausal women. The
diﬀerence was statistically signiﬁcant and there were not diﬀerences
between the two groups in the number of awakenings and the elapsed
time to fall asleep in the leisure time. The complexity of the scale limits
its use in the consultation of climacteric women.
3.7. The St Mary's Hospital Sleep Questionnarie (SMHSQ)
The St Mary's Hospital Sleep Questionnaire is a tool speciﬁcally
designed to assess sleep in patients, testing the duration and quality of
sleep the previous night while they are in the hospital. The items
inquire about sleep issues, including latency, restlessness, insomnia
and alertness in the morning. This scale has 14 multiple choice
questions with short answers. It was applied at the ﬁrst time in four
groups of people, surgical patients, others with medical treatment, the
others with psychiatric treatment and the last one with healthy
volunteers [37] [Appendix G].
Pien [38] found signiﬁcant associations between the poor quality of
sleep and the presence of hot ﬂashes, smoking, high levels of anxiety,
stress and depression in a climacteric population in 2008. He also
examined associations among these same risk factors and the ninth
question in the questionnaire “How did you sleep last night? ”. The
Cronbach's alpha of the scale in this article was 0.76, indicating strong
internal consistency.
Other study found a high prevalence of moderate/severe poor sleep
in 255 women recruited on Penn Ovarian Again Study Cohort Findings
women. Sleep status at premenopausal baseline and concurrent hot
ﬂashes predicted strongly and consistently poor sleep in the menopau-
sal transition. Overall, poor sleep does not increase around the ﬁnal
menstrual period and occurs frequently in the absence of hot ﬂashes,
indicating that sleep diﬃculties in the menopausal transition in healthy
women are not simply associated with ovarian decline [12].
4. Discussion
The SD are very important problems with many expressions,
complex etiology with associated factors [6,39]. There are many scales
that have been developed and validated in several areas of the health;
they are available to analyze the sleep behavior and to establish
subjectively the presence of SD. To study the general population in
speciﬁc groups like elderly, children and adolescent patients with
dementia and other diseases has been proposed.
The most widely used scales to study climacteric are Insomnia
Severity Index (ISI), Athens Insomnia Scale (AIS) and Pittsburgh
Quality of Sleep Index (PSQI), with validation in several countries
and languages, which make them attractive to assess the prevalence
and factors associated with SD. The ﬁrst two of them allow setting
aspects speciﬁcally related to insomnia, whose prevalence increases in
postmenopausal women, increasing in 60% while in premenopausal
women 40%. The four major causes proposed to explain the poor
quality of sleep are: sleep disruption associated with hot ﬂashes,
increase of sleep apnea, mood disorder and inadequate sleep hygiene
leading to chronic insomnia [40].
The PSQI was developed to provide a reliable, valid and standar-
dized measure of quality of sleep, to discriminate between “good” and
“poor” sleepers, to procure an easy index to use in patients, clinicians
and researchers to understand and to provision a brief, clinical and
useful assessment of a variety of sleep disturbances that might aﬀect
quality of sleep. It has been widely used in climacteric and it is a proper
tool to be applied [5,9,28].
The Insomnia Severity Index, Athens Insomnia Scale, Pittsburgh
Quality of sleep Index (PSQI) and Basic Nordic Sleep Questionnaire
(BNSQ) have been used to check modiﬁcations in the prevalence of SD
in women with hormonal therapy for the treatment of menopause
symptoms, demonstrating its eﬃcacy in these scenes [5,9,18,36].
The PSQI could be diﬃcult to apply as a self-administered instru-
ment in patients with low educational levels. The internal consistency
determined by Cronbach's alpha was appropriated for the 19 items and
7 components. The scores of the items, the components and the total
value remained stable during the time of Test-retest. The cutoﬀ point of
ﬁve has been used to deﬁne the population with poor quality of sleep
[25].
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Perimenopausal and postmenopausal women usually sleep less;
they have more insomnia and more necessity of medication to sleep
than those premenopausal ones [8]. However, they usually do not talk
to their doctors voluntarily and the health providers do not ask about
aspects related to it. Insomnia, nonrestorative sleep and excessive
daytime sleepiness are frequent after menopause [6]. Both situations
contribute to raise the alteration, to create empirical measures and to
favor the dependence on drugs.
The application of these scales that assess sleep, especially the
Athens Insomnia Scale (AIS) to assess the insomnia and Jenkins Sleep
Scale (JSS) to check the general condition of sleep could be applied
before or after the consultation. This could be the beginning to identify
the sleep disorders in women during climacteric.
The Sleep is essential for a healthy immune, metabolic, physical and
cognitive system and also for a good quality of life. The Jenkins Sleep
Scale (JSS) is helpful due to its brevity and easy application, which
oﬀers a panoramic view of the sleep condition [6].
Freeman [12] has proposed that lack of sleep, classiﬁed as
moderate or severe before menopause, could be predictor of severe
SD in postmenopause, OR:3.5 [CI95%: 2.5–5.1]. Other factors also
could indicate the presence of SD: Moderate or severe hot ﬂushes:
OR:1.7[CI95%:1.5–2.1]; anxiety: OR:1.1 [CI95%:1.08–1.12]; depres-
sion: OR:2.1[CI95%:1.7–2.6] and previous clinical proﬁle of depres-
sion: OR:2.0[CI95:1.51–2.86]. It was not found statistical signiﬁcance
with obesity, perceived stress, to smoke, estradiol levels, FSH, and
inhibin B. These were risk factors to SD; but there are controversies
and diﬀerent positions about the role of reproductive hormones in the
balance between sleep and sleeplessness, and the presence or compli-
cation in some SD.
The incidence of Sleep-disordered breathing (SDB) is other cause of
bad sleep in perimenopausal women with incidence that increases in
postmenopause [12]. After controlling the age, the body max index and
other factors of quality of life, postmenopausal women had 2.6 times
more SDB than premenopausal women. The suggested mechanisms to
this apparent increment include the changes in the distribution of body
fat with a rise in the waist and hip measurements; as well as the
decrease of sexual hormones [41–43]. The clinical proﬁle has been
named sleep apnea syndrome or hypopnea and is frequent in women in
middle-age; its symptoms are loud snoring, awakenings during sleep,
reduction in the saturation of oxygen, to feel restless sleep and
excessive daytime sleepiness. Severe episodes and the occurrence of
SD for a long period have been associated with cardiovascular diseases
[8,44].
The STOPBang Sleep Apnea Questionnaire is a speciﬁc tool to
estimate the SDB presence. It has eight questions to answer “yes” or
“no”. Do you snore loudly (louder than talking or loud enough to be
heard through closed doors)? Do you often feel tired, fatigued, or sleepy
during daytime? Has anyone observed you stop breathing during your
sleep? Do you have or are you being treated for high blood pressure?
BMI more than 35 kg/m2? Age over 50 years old? Neck circumference
> 16 in. (40 cm)? or Male? [45].
These are the evaluation criteria for general population: low risk of
obstructive sleep apnea: aﬃrmative answers for none or two questions.
Intermediate risk: aﬃrmative answer for three or four questions. High
risk: it is set by the four following considerations. First: aﬃrmative
answer for ﬁve or eight questions. Second: aﬃrmative answer for two
or more of the ﬁrst four questions from male sex scale. Third:
aﬃrmative answer for two or more of the ﬁrst four questions plus
IMC > 35 kg/m2. Fourth: aﬃrmative answer for two or more than the
ﬁrst four questions plus neck circumference (equal to or greater than
43 in men or 41 in women). If three or more answers are aﬃrmative is
prudent that a SD specialist will check the patient [6,45]. There have
not been identiﬁed studies to assess speciﬁcally SDB, with the
STOPBang Sleep Apnea Questionnaire, in climacteric women.
Other scale to assessment SDB is The Berlin Questionnaire,
speciﬁcally proposed for obstructive sleep apnea-hypopnea syndrome
(OSAHS). It is the most common type of SDB characterized by airway
narrowing during sleep that leads to respiratory disruption, hypoxia
and sleep fragmentation. The incidence of OSAHS in the adult female
population is 2%. Despite this, the syndrome seems to be under-
diagnosed. Pataka [46] evaluated ﬁve diﬀerent questionnaires for
assessing sleep apnea syndrome in a sleep clinic. One thousand eighty
hundred ﬁfty three (74.4% males) patients (mean age 52 ± 14 years;
mean body mass index 32.8 ± 7 kg/m2) of a sleep clinic were studied
retrospectively. Berlin questionnaire had the highest sensitivity, OR,
and AUC, but rather low speciﬁcity. This does not identify studies that
involved especially climacteric women.
The evaluation of common causes of SD in middle age women has
shown that the primary disorders called apnea syndrome and restless
leg syndrome are common in this population [8]. By means of
laboratory tests was observed that the 53% of women presented apnea
syndrome and restless leg syndrome or both in a study carried out in
climacteric women that were experiencing lack of sleep [46,47]. The
best predictors to detect objectively the poor quality of sleep were
apnea, restless leg syndrome and awakenings at night. The best
predictors to detect subjectively the poor quality of sleep with PSQI
were detected as the presence of anxiety and hot ﬂashes at the ﬁrst half
of the night. The adequate management of hot ﬂashes have been
proved to improve some manifestations related to lack of sleep; even
so, it does not inﬂuence in some primary sleep disorders. On the other
hand, SD could be associated with higher morbidity and mortality in
signiﬁcant magnitudes. For that reason, is necessary to pay careful
attention, as well as to increase the sensibility of the specialist in SD
cases and its implications in health women [8].
The Epworth Sleepiness Scale (ESS) allows identifying speciﬁcally
the daytime somnolence, which also has demonstrated to be a risk
factor in the worsening of quality of life during menopause. This scale
is easy to apply and allow establishing aspects related to the impact of
the sleep disorder in the next day. Additionally, it is very helpful to
identify modiﬁcations in the quality of life in women as consequence of
SD presence; the aforementioned impact has been considered essential
and important [9]. The ESS was the only one identiﬁed to determine
the pathological daytime somnolence; it helps to precise the impact of
sleep in daily rest conditions carry out by women [30,31].
It should always explore aspects related to quality of sleep and the
specialist must consider questions that allow identifying SD when
climacteric women are evaluated. The identiﬁed scales have validity
and are good tools to identify subjectively SD and to measure the
quality of sleep. It should be noted that sleep absence is not only caused
by menopause or hot ﬂashes. The common perception of sleep absence
is associated with the ovarian hormonal reduction around the age of
menopause, in some women the baseline before menopause has
worsened with the elderly [12].
Although, the sleep patterns and SD inﬂuences in the personal and
social habits, those aspects are not considered in the scales. It was
observed that scales do not explore speciﬁc habits neither cultural or
ethnic conditions. Environmental inﬂuences which could generate
important modiﬁcations.
Through a convenience selection carried out by virtual platform, the
interval of time that was considered, the selected languages and
databases restrict this study because there are other scales to assess
SD in climacteric that have not been identiﬁed; but this study has the
most widely used scales which have demonstrated the validity to study
SD. However, there are other ways to detect SD, for instance, with
scales to analyze insomnia, sleep records, consultations and psycholo-
gical tests. All these scales identify subjectively the SD.
A version of the PSQI includes ﬁve questions to be answered by the
couple or the carer of the person evaluated. Only laboratory studies
such as polysomnography and actigraphy could identify objectively
patterns of SD. The initial sleep diagnostic must be carried out with
primary scales of health care according to the results. It is possible to
get objective evidence and specialized medical care for comorbidities or
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sleep disturbances. The complexity to advance the studies, laboratory
equipment requirements and limitations in the information to make
their diagnosis are restricted for speciﬁc situations and specialized
applications.
5. Conclusion
There are validated and available scales in multiple languages to
assess generally or speciﬁcally SD, insomnia and excessive daytime
sleepiness in climacteric women. They could be used for population
studies, to determine its therapeutic eﬃcacy in interventions; even
some of them could be applied within health care by doctors with
various levels of specialization.
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Table A1
Insomnia severity index.
Insomnia problema 0 1 2 3 4
1. Difficulty falling asleep None Mild Moderate Severe Very severe
2. Difficulty staying asleep None Mild Moderate Severe Very severe
3. Problems waking up too early None Mild Moderate Severe Very severe
4. How satisfied/dissatisfied are you with your current sleep pattern? Very satisfied Satisfied Moderate
satisfied
Dissatisfied Very dissatisfied
5. How noticeable to others do you think your sleep problem is in terms of impairing the
quality of your life?
Not at all
noticeable
A Little Somewhat Much Very much
noticeable
6. How worried/distressed are you about your current sleep problem? Not at all worried A Little Somewhat Much Very much worried
7. To what extent do you consider your sleep problem to interfere with your daily
functioning (e.g. daytime fatigue, mood, ability to function at work/daily chores,
concentration, memory, mood, etc.) currently?
Not at all
Interfering
A Little Somewhat Much Very much
interfering
Table B1
Athens insomnia Scale.
0 1 2 3
1. Sleep induction (time it takes you to fall asleep after turning-off
the lights)
No problem Slightly delayed Markedly delayed Very delayed or did not sleep at all
2. Awakenings during the night No problem Minor problem Considerable problem Serious problem or did not sleep at all
3. Final awakening earlier than desired Not earlier A little earlier Markedly earlier Much earlier or did not sleep at all
4. Total sleep duration Sufficient Slightly insufficient Markedly Insufficient Very insufficient or did not sleep at all
5. Overall quality of sleep (no matter how long you slept) Satisfactory Slightly unsatisfactory Markedly Unsatisfactory Very unsatisfactory or did not sleep at
all
6. Sense of well-being during the day Normal Slightly decreased Markedly decreased Very decreased
7. Functioning (physical and mental) during the day Normal Slightly decreased Markedly decreased Very decreased
8. Sleepiness during the day None Mild considerable Intense
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Table C1
Pittsburgh sleep quality index (PSQI).
The following questions relate to your usual sleep habits during the past month only
1. When have you usually
gone to bed?
Bed Time:
2. How long (in minutes) has
it taken you to fall asleep
each night?
Number of Minutes:
3. What time have you
usually gotten up in the
morning?
Getting up time:
4. How many hours of actual
sleep did you get at night?
Hours of sleep per night:
0 1 2 3
5. During the past month,
how often have you had
trouble sleeping because
you
Not
during the
past
month
Less
than
once a
week
Once or
Twice a
week
Three or
more
times a
week
5-A. Cannot get to sleep within
30 min
Not
during the
past
month
Less
than
once a
week
Once or
twice a
week
Three or
more
times a
week
5-B. Wake up in the middle of
the night or early morning
Not
during the
past
month
Less
than
once a
week
Once or
twice a
week
Three or
more
times a
week
5-C. Have to get up to use the
bathroom
Not
during the
past
month
Less
than
once a
week
Once or
twice a
week
Three or
more
times a
week
5-D. Cannot breathe
comfortably
Not
during the
past
month
Less
than
once a
week
Once or
twice a
week
Three or
more
times a
week
5-E. Cough or snore loudly Not
during the
past
month
Less
than
once a
week
Once or
twice a
week
Three or
more
times a
week
5-F. Feel too cold Not
during the
past
month
Less
than
once a
week
Once or
twice a
week
Three or
more
times a
week
5-G. Feel too hot Not
during the
past
month
Less
than
once a
week
Once or
twice a
week
Three or
more
times a
week
5-H. Have bad dreams Not
during the
past
month
Less
than
once a
week
Once or
twice a
week
Three or
more
times a
week
5-I. Have pain Not
during the
past
month
Less
than
once a
week
Once or
twice a
week
Three or
more
times a
week
5-J. Other reason (s), please
describe, including how
often you have had trouble
sleeping because of this
reason (s):
Not
during the
past
month
Less
than
once a
week
Once or
twice a
week
Three or
more
times a
week
6. During the past month,
how often have you taken
medicine (prescribed or
“over the counter”) to help
you sleep?
Not
during the
past
month
Less
than
once a
week
Once or
twice a
week
Three or
more
times a
week
7. During the past month,
how often have you had
trouble staying awake
while driving, eating
meals, or engaging in
social activity?
Not
during the
past
month
Less
than
once a
week
Once or
twice a
week
Three or
more
times a
week
8. During the past month,
how much of a problem
has it been for you to keep
up enthusiasm to get
things done?
Not
during the
past
month
Less
than
once a
week
Once or
twice a
week
Three or
more
times a
week
9. During the past month, Very good Fairly Fairly Very bad
(continued on next page)
Table C1 (continued)
The following questions relate to your usual sleep habits during the past month only
how would you rate your
sleep quality overall?
good bad
Table D1
Epworth sleepiness Scale.
0 1 2 3
Sitting and Reading Would
never
doze
Slight
chance of
dozing
Moderate
chance of
dozing
High
chance of
dozing
Watching TV Would
never
doze
Slight
chance of
dozing
Moderate
chance of
dozing
High
chance of
dozing
Sitting, inactive in a
public place (e.g. a
theater)
Would
never
doze
Slight
chance of
dozing
Moderate
chance of
dozing
High
chance of
dozing
Lying down to rest in the
afternoon when
circumstances permit
Would
never
doze
Slight
chance of
dozing
Moderate
chance of
dozing
High
chance of
dozing
Sitting and talking to
someone
Would
never
doze
Slight
chance of
dozing
Moderate
chance of
dozing
High
chance of
dozing
Sitting quietly after a
lunch without alcohol
Would
never
doze
Slight
chance of
dozing
Moderate
chance of
dozing
High
chance of
dozing
In a car, whirl stopped
for a few minutes in
the traﬃc
Would
never
doze
Slight
chance of
dozing
Moderate
chance of
dozing
High
chance of
dozing
Table E1
Jenkins sleep scale (JSS) evaluated in the last month.
How often in the past
month did you:
0 1 2 3 4 5
1. Have trouble falling
asleep
Not
at all
1–3 days 4–7 days 8–14
days
15–
21
days
22–
31
days
2. Wake up several
times per night
Not
at all
1–3 days 4–7 days 8–14
days
15–
21
days
22–
31
days
3. Have trouble staying
(including waking
far too early)
Not
at all
1–3 days 4–7 days 8–14
days
15–
21
days
22–
31
days
4. Wake up after your
usual amount of
sleep feeling tired
worn out
Not
at all
1–3 days 4–7 days 8–14
days
15–
21
days
22–
31
days
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